Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Sather

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study GroupW A Bleyer, H N Sather, H J Nickerson, et al.
Blood|December 10, 1999
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer groupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studiesP S Gaynon, B C Bostrom, R J Hutchinson, et al.
Cancer|November 7, 1998
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer GroupF M Uckun, J B Nachman, H N Sather, et al.
Leukemia & Lymphoma|February 27, 1999
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group studyF M Uckun, B J Waurzyniak, H N Sather, et al.
Cancer|April 13, 2000
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study GroupW A Bleyer, H N Sather, H J Nickerson, et al.
Blood|December 10, 1999
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer groupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studiesP S Gaynon, B C Bostrom, R J Hutchinson, et al.
Cancer|November 7, 1998
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer GroupF M Uckun, J B Nachman, H N Sather, et al.
Leukemia & Lymphoma|February 27, 1999
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group studyF M Uckun, B J Waurzyniak, H N Sather, et al.
Cancer|April 13, 2000
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Pageof 9